@pippa-matt.bsky.socialOur work with the #Mongolian community in #London 'MoLo' set out to raise awareness, develop pathways to care, collect data, and support lab research 🧪
#MedSky #LiverSky #PublicHealth #HBV #HIV #InclusionHealth
@crick.ac.uk @uclh.bsky.social @uclhresearch.bsky.social
www.crick.ac.uk/news/2026-09...
@salvivicidomini.bsky.social𒀮𒀮Modified #HIV #drug reverses #vision loss and #paralysis in #multiple #sclerosis model. -- Wednesday, September 23, 2026. National Institutes of Health𒀮𒀯
A new National Institutes of #Health (NIH)-funded study indicates that the experimental drug kamuvudine-9 (K-9) ...... lnkd.in/p/dmvTHmvS
@salvivicidomini.bsky.social𒀮𒀮Modified #HIV #drug reverses #vision loss and #paralysis in #multiple #sclerosis model. -- Wednesday, September 23, 2026. National Institutes of Health𒀮𒀯
A new National Institutes of #Health (NIH)-funded study indicates that the experimental drug kamuvudine-9 (K-9) ...... lnkd.in/p/dmvTHmvS
@toppnews.bsky.social@toppnews.bsky.social#AIDS #HIV #New York #Big Apple 🗽 #school
🌐 www.newsmart.ch
@toppnews.bsky.social#HIV #Ukraine #SlavaUkraini 🔱 🌻 💪🏼 #Zelensky
🌐 www.newsmart.ch
@gmj-georgia.bsky.social🔬 New phase 1 trial in Nature Medicine: Bispecific antibody 10E8.4/iMab safely targets HIV through dual mechanisms in both HIV+ an… #Broadlyneutralizingantibody #HIV #Monoclonalantibody #Phase1trial #Therapeuticdevelopment #Broadlyneutralizingantibody #HIV #Monoclonalantibody #Phase1trial #Ther…
@topnewsde.bsky.social
@heyfriend-1.bsky.social
@soumya-goblue.bsky.socialI have a particular interest in aging with #HIV (now that I am done with my #healthpolicy fellowship I want to start working on HIV specialist credentialing) and aging with diseases like Down Syndrome where “Geriatric syndromes” start at 50+ and I honestly think we may need to make that universal.
@adapadvocacy.bsky.socialState AIDS Drug Assistance Programs provide lifesaving #HIV medicines to uninsured or underinsured patients, but the program is in financial trouble. People living with HIVAIDS are already on waiting lists in Iowa and Utah, and more are expected to follow. Learn more: www.youtube.com/watch?v=jxt-...
@avac.org“We are dismayed & concerned that NIH’s hasty actions to reorganize #NIAID are threatening the incredible progress that has been achieved toward #HIV treatment & prevention.”
AVAC made these comments to the NIAID Council & ARAC urging NIH to withdraw the proposed reorg, tinyurl.com/NIADcomment
@anonturk.bsky.social
@capjd.bsky.socialAn outstanding Moth story
#LGBTQ #HIV #AIDS #QUEERPOSITIVE
@rickguasco.bsky.socialBefore going through the photos taken yesterday for A Day with HIV, I’m taking my #HIV medication.
@monalisarout1701.bsky.socialTimely response to HIV treatment failure is crucial.
📊 72.2% returned to clinic within 6 months.
🧪 70.1% had repeat VL testing within 1 year.
💊 85.0% on TLD resuppressed vs. 58.2% on TLE.
#HIV #TreatmentFailure #Zambia https://tnyp.me/QriA7fax/s
@eclinicalmed.bsky.social📢NEW: September issue now online featuring #NoonanSyndrome, #Stroke, #HIV, #Spondyloarthritis, #Diabetes, #Sepsis, #Asthma, and more with our editorial on the rise of early-onset cancer
…all available #free, #OpenAccess❗️
Read more here: www.thelancet.com/issue/S2589-...
Attribution: Getty
@taghivscience.bsky.socialConstitutive natural killer cell features associated with post-treatment control of SIV infection in the pVISCONTI study www.nature.com/articles/s41... (open access) @natcomms.nature.com #HIV
@taghivscience.bsky.socialIn vivo effect of anti-PD-1 on HIV-specific CD8+T-cells in men with #HIV www.nature.com/articles/s41... (open access) @natcomms.nature.com
@taghivscience.bsky.socialMaternal #HIV Exposure Is Associated With Transient Transcriptional Changes in Monocytes and Natural Killer Cells in Early Infancy academic.oup.com/jid/advance-... (open access) @jidjournal.bsky.social